Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-12-30
2000-10-10
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514 3, 514 12, 514 34, 514 49, 514245, 514615, 514648, 560155, 560179, 560187, 560199, A61K 31225, C07C 69612, C07C 6967
Patent
active
061302481
ABSTRACT:
This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers, treating gastrointestinal disorders, treating blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, treating insulin-dependent patients, treating cystic fibrosis patients, inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors, augmenting expression of a tumor suppressor gene and inducing tolerance to an antigen. The methods of the invention use tricarboxylic acid substituted oxyalkyl esters.
REFERENCES:
patent: 2940855 (1960-06-01), Beavers et al.
patent: 3219630 (1965-11-01), Sidi
patent: 3293220 (1966-12-01), Minami et al.
patent: 3336262 (1967-08-01), Sidi
patent: 3720706 (1973-03-01), Lapporte et al.
patent: 3812176 (1974-05-01), Lapporte et al.
patent: 3931412 (1976-01-01), Kensler, Jr. et al.
patent: 4012526 (1977-03-01), Kensler, Jr. et al.
patent: 4105681 (1978-08-01), Bollag et al.
patent: 4123552 (1978-10-01), Kensler, Jr. et al.
patent: 4198416 (1980-04-01), Koeda et al.
patent: 4215215 (1980-07-01), Bollag et al.
patent: 4541944 (1985-09-01), Sanderson
patent: 4545784 (1985-10-01), Sanderson
patent: 4613505 (1986-09-01), Mizushima et al.
patent: 4699925 (1987-10-01), Uchida et al.
patent: 4760057 (1988-07-01), Alexander
patent: 4885311 (1989-12-01), Parish et al.
patent: 4900478 (1990-02-01), Gross
patent: 4916230 (1990-04-01), Alexander
patent: 5025029 (1991-06-01), Perrine
patent: 5158773 (1992-10-01), Gross
patent: 5185436 (1993-02-01), Villa et al.
patent: 5196567 (1993-03-01), Uchida et al.
patent: 5200553 (1993-04-01), Nudelman et al.
patent: 5216004 (1993-06-01), Perrine
patent: 5569675 (1996-10-01), Rephaeli et al.
patent: 5710176 (1998-01-01), Rephaeli et al.
Brant and Conklin, "Acrolein Diacylates", Chem. Abstracts, vol. 40, p. 3127, 1946.
Carstea, et al., "Analogues of Butyric Acid that increase the Expression of Transfected DNAs", Biochem. Biophys. Res. Com., vol. 192, No. 2, pp. 649-656, 1993.
Cheng, et al., "Functional Activation of the Cystic Fibrosis Trafficking Mutant deltaF508-CFTR by Overexpression", American Journal of Physiology, vol. 268, No. 4, pp. L615-L624, 1995.
Ingram and Thomas, "The Electron Impact Induced Fragmentation of Geminal Dialkanoates", Organic Mass Spectrometry, vol. 12, No. 4, pp. 216-221, 1977.
Kamiya, et al., "Pharmaceutical Patches Comprising Water-Soluble Adhesive Sheet", Chem. Abstracts, vol. 126, Abstract 162263, 1997.
Man, et al., "Boron Fluoride Catalyzed Addition of Aliphatic Anhydrides to Aldehydes", J. Am. Chem. Soc., pp. 847-848, 1950.
Miller, et al., "Clinical Pharmacology of Sodium Butyrate in Patients with Acute Leukemia", Eur. J. Cancer Clin Oncol. vol. 23, No. 9, pp. 1283-1287, 1987.
Mosher and Kehr, "The Oxidation of Aliphatic Esters with Lead Tetraacetate", J. Am. Chem. Soc., vol. 82, pp. 5342-5345, 1960.
Nielsen and Bundgaard, "Evaluation of Glycolamide Esters and Various Other Esters of Aspirin as True Aspirin Prodrugs", J. Medicinal Chem., vol. 35, pp. 687-694, 1992.
Novogrodsky, et al., "Effect of Polar Organic Compounds on Leukemic Cells", Cancer, vol. 51, No. 1, pp. 9-14, 1983.
Nudelman, et al., "Novel Anticancer Prodrugs of Butyric Acid", J. Med. Chem., vol. 35, pp. 687-694, 1992.
Oh, et al., "Convenient Synthesis of Geminal Biscarboxylates: Searching for an Efficient Route to HR 916B", Korean J. Med. Chem., vol. 6, No. 2, pp. 259-262, 1996.
Rephaeli, et al., "Butyrate-Induced Differentiation in Leukemic Myeloid Cells: in vitro and in vivo Studies", International Journal of Oncology,vol. 4, No. 6, pp. 1387-1391, 1994.
Sanderson, et al., "Bleach Compositions", Chem. Abstracts, vol. 102, Abstract 47772, 1985.
Sher, et al., "Extended Therapy with Intravenous Arginine Butyrate in Patients with Beta--Hemoglobinopathies", New England Journal of Medicine, vol. 332, No. 24, pp. 1606-1610, 1995.
Scheeren and Tax, "Mixed Acylals; Synthesis of Alkylidene Carboxylate Formates", Synthesis, vol. 3, pp. 151-153, 1973.
Smith, et al., "Incorporation of Tributyrin Enhances the Expression of a Reporter Gene in Primary and Immortalized Cell Lines", Biotechniques, vol. 18, No. 5, pp. 852-855, 1995.
Stamatoyannopoulos, et al., "Therapeutic Approaches to Hemoglobin Switching in Treatment of Hemoglobinopathies", Ann. Rev. Med., vol. 43, pp. 497-522, 1992.
Tang, et al., "Butyrate-Inducible and Tumor-Restricted Gene Expression by Adenovirus Vectors", Cancer Gene Therapy, vol. 1, No. 1, pp. 15-20, 1994.
Toyobo Co., "Electroconductive Resin Compositions", Chem. Abstracts, vol. 103, Abstract 125229, 1985.
Tomiska and Spousta, "Low-Molecular Polyoxymethylene Diacetates from Trioxane", Angew. Chem. Internat. Edit., vol. 1, No. 4, p. 211, 1962.
Nielson and Bundgaard, "Evaluation of Glycolamide Esters and Various Other Esters of Aspirin as True Aspirin Prodrugs", J. Medicinal Chem. vol. 32, pp. 727-734, 1989.
Kamiya et al., Chemical Abstracts, vol. 126, abstract 162263, 1997.
Oh et al., Chemical Abstracts, vol. 126, abstract 131271, 1997.
Toyobo Co., Chemical Abstracts, vol. 103, abstract 125229, 1985.
Sanderson et al., Chemical Abstract, vol. 102, abstract 47772, 1985.
Nudelman Abraham
Rephaeli Ada
Bar-Ilan University
Beacon Laboratories, Inc.
Mor Research Applications Ltd.
Raymond Richard L.
LandOfFree
Tricarboxylic acid-containing oxyalkyl esters and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricarboxylic acid-containing oxyalkyl esters and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricarboxylic acid-containing oxyalkyl esters and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2257356